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Abstract
About 200 journal articles reported research on Tourette syndrome and other
tic disorders in 2014. Here we briefly summarize a few of the reports that
seemed most important or interesting, ranging from animal models to human
studies. Readers can comment on our choices or provide their own favorites
using the tools on the online article.
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REVISED Amendments from Version 1
      
We revised the article to address the thoughtful comments by the
two reviewers. We added most of the suggested references into
the text or Box 1; suggested articles with final publication dates in
2015 appear in Box 2. Readers can find additional citations in the
reviewers’ comments. We had inadvertently omitted the ecopipam
reference that both reviewers suggested, and we remedy that
now in a new section on pharmacotherapy. We also added
comments on DBS, and added the recent consensus statement
to Box 2. We reorganized the papers by theme, as suggested.
We also corrected Figure 1 and supply with it the updated iPython
notebook file and the HTML copy. Replies to specific reviewer
comments appear in the “Author Response” boxes below.
See referee reports

Introduction
The available information on Tourette syndrome (TS) is steadily
increasing (Figure 1), and keeping up with the published literature is therefore an increasing challenge. This article introduces a
Highlights article to the F1000Research: Tics channel, to showcase some of the most noteworthy publications from the previous
calendar year.

Methods
This article is not a systematic review but summarizes the authors’
personal views. We used the following approach to identify pertinent publications: personal reading, asking colleagues for suggestions, F1000Prime, and a PubMed search (Figure 1, legend).

The search string “(“Tic Disorders”[MeSH] OR Tourette NOT
Tourette[AU]) AND 2014[PDAT] NOT 2015[PDAT]” produced
201 references (one of which was actually published in 2013). Of
course this approach will miss some TS-related publications that do
not appear in PubMed, or that will be indexed in PubMed in coming
months. We further limited the scope to articles written in English
that had final publication dates in 2014.
Dataset 1. Publications on Tourette syndrome: 1950–2014
http://dx.doi.org/10.5256/f1000research.6209.d79935
This file contains the PubMed data used to generate Figure 1 in the
associated article.

Results
Here we present examples of TS research published in 2014 that we
thought had notable findings or the potential to stimulate additional
research in TS.

Etiology
A genetic clue. To this point, the highly heritable nature of TS has
remained a tantalizing clue rather than the key to understanding
pathophysiology. However, recently an international collaboration
reported an intriguing result. A recent genome-wide association
study had identified a number of single nucleotide polymorphisms
(SNPs) as possibly associated with TS. The group genotyped 42 of
these SNPs in over 1200 individuals, half from unrelated TS cases
and half from controls matched for ancestry69. A risk score based on
each individual’s alleles at the 42 SNPs was able to predict diagnosis significantly better than chance; this result supports the conclusion that at least some of these SNPs are true risk alleles for TS.
One of the SNPs remained significant after correction for multiple
comparisons, and the authors discuss nearby genes that could produce relevant changes in brain structure or function.

Figure 1. Publications on Tourette syndrome. The number of new
publications on Tourette syndrome or other tic disorders each year
was estimated from PubMed. The colored line represents locally
weighted scatterplot smoothing (LOWESS) of the primary data.

Pathophysiology
Mice without histamine. Castellan Baldan et al.1,2 report on characterization of a possible animal model for Tourette syndrome, chosen
because of a family with Tourette syndrome linked to a loss-of-function
mutation in the histidine decarboxylase gene3,4. Histidine decarboxylase knock-out mice5 exhibited tic-like stereotypies after
a d-amphetamine challenge (see Figure 1, panel E in ref. 2) and
increased striatal dopamine during the nocturnal (awake) period.
The amphetamine-induced stereotypies were decreased by administration of the dopamine D2 receptor antagonist haloperidol, and
histamine infusion reduced striatal dopamine levels and amphetamine-induced stereotypies. Prepulse inhibition and dopamine
D2/D3 receptor binding were altered in both the knock-out mice
and the small sample of known human carriers of the histidine
decarboxylase mutation.

PubMed was searched using the search string “(“Tic Disorders”[MeSH]
OR Tourette NOT Tourette[AU]) AND year[PDAT] NOT year+1[PDAT]”
for each year from 1950 through 2014. (This strategy assigns articles
to the year in which the final publication appeared, to prevent doublecounting “early online” and final publication dates for about 250
publications since 2005). The graph was generated by matplotlib in
python (see Supplementary material).

Other animal models. Appropriate animal models of TS could provide pathophysiological insights or speed identification and development of novel treatments. Two informative reviews of mouse
models for tic disorders were published in 20146,7. Both reviews
agreed that animal models need appropriate face, constructive, and
predictive validity to be useful, but Godar et al. argue that a focus
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on intermediate phenotypes, which involve more elemental neuroanatomic and functional deficits, results in animal models with
specific measurable parameters6. They then describe several lines of
knockout mutant mice using candidate genes for TS, animal models
examining the link between early neuroinflammation and TS pathogenesis, and pharmacological models. Pappas et al. include mouse
models for Rett’s syndrome and primary dystonia in addition to
TS/OCD7. They developed a test battery to characterize variations
across mouse strains in terms of putative tic-like symptoms (i.e.,
head twitches and body jerks induced by administration of a selective 5-HT2 receptor agonist), amphetamine-induced stereotypies
(i.e., wall-rearing and head-down sniffing), perseverative responding on an attentional set-shifting task involving binary choice, and
spontaneous locomotion8. Although DOI administration produced
head twitches and body jerks in all subjects, the SJL and C57 mice
spent a longer time performing body jerks than the ABH and CD1
mouse strains, with the C57 mice also showing increased elevated
levels of spontaneous locomotion and increased perseveration on
the set-shifting task. The authors argue that using specific behavioral parameters to investigate differences among mouse strains will
allow identification of strains that may represent “pure” TS while
other strains may represent TS along with behaviors that reflect
common co-morbidities (e.g., hyperactivity, compulsions).

tensor imaging identified lower connectivity values (CI), consistent with altered white matter structure, in almost two-thirds of the
tracts examined in 15 adults with “pure” TS compared to healthy
controls15. After correction for multiple comparisons, 10 tracts were
identified as having significantly lower CI in the patient group. Two
of these involved connections between the SMA or preSMA and
pallidum, and were excluded from further analysis. Correlations
between YGTSS scores and individual tract CI values were found
for the M1–OFC and preSMA–putamen, although none of these
remained significant after correcting for multiple comparisons.

At the November, 2014, annual meeting of the Society for Neuroscience, Xu et al. presented evidence that removing about half of
the cholinergic interneurons in the dorsolateral striatum reproduced
some features of TS in a rodent model9; see also10. This model was
inspired by the fascinating autopsy studies that found decreased
numbers of striatal interneurons in Tourette syndrome11. At the
same meeting, McCairn and colleagues presented a non-human primate model with the GABA antagonist bicuculline injected into the
putamen or nucleus accumbens; this produced a variety of movements and vocalizations, including some tics with reasonable face
validity12. As the validity of animal models increases, so does the
expectation that they may provide additional insights concerning
TS and its associated comorbidities.

An overview of SMA syndromes and related research explores
how the SMA may be involved in both initiation and inhibition of movements along with providing a tonic interhemispheric
balance17. This concept of interhemispheric balance may explain
why both SMA activation and SMA inhibition can reduce tics, and
may also explain why SMA activation can produce echophenomena
in healthy controls.

A look inside: neuroimaging studies. Neuner et al.13 examined ticrelated neural activity in ten adults with TS using fMRI, estimating the timing of brain activity (as reflected by BOLD signal) to a
resolution shorter than that of the individual image acquisitions by
taking advantage of the essentially random temporal distribution of
tics with respect to the timing of image acquisition. This strategy is
reminiscent of the event-related analysis of positron emission tomography regional brain blood flow images developed by Silbersweig
and colleagues14. Two seconds before tic occurrence, BOLD activity
increased in the supplementary motor area (SMA), ventral primary
motor cortex, primary sensorimotor cortex and parietal operculum.
One second before tics, activation was seen in the anterior cingulate, putamen, insula, amygdala, cerebellum and extrastriatal visual
cortex, and at tic onset activation was seen in the primary motor
and somatosensory cortices, the thalamus, and the central operculum. Cortical structure BOLD signal clearly preceded signal in
subcortical structures. In addition, resting state data demonstrated
that network strength in the same SMA regions correlated with ratings of recent tic severity; the authors suggest that abnormal baseline activity in the SMA may contribute to tic generation. Diffusion

In another fMRI study, adults with “pure” TS performed similarly to
control subjects on a stop signal reaction time task, consistent with
the conclusion that tics occur without broadly insufficient action
inhibition16. However, TS subjects exhibited greater dorsal premotor activation during the Go condition compared to the StopSuccess
condition. Increased right pre-SMA activation was associated with
successful stop trials in healthy controls. For TS subjects, activation
in the SMA proper during StopSuccess compared to Go trials was
positively correlated with motor tic frequency. The involvement of
SMA in both proactive and reactive control was discussed and the
authors suggest that greater SMA activation in patients with higher
tic frequency may reflect a stronger need for tic inhibition.

A derived measure called regional homogeneity (“ReHo”) in the left
inferior frontal gyrus increased in 14 subjects with pure TS during tic
suppression compared to free ticcing18. ReHo increases were positively correlated with participants’ ability to inhibit their tics both
inside and outside the scanner. In another report from the same group,
grey matter volumes in the right inferior frontal gyrus and left frontal
pole were reduced in adults with “pure” TS compared to healthy controls but these reductions were not correlated with Yale Global Tic
Severity Scale (YGTSS) scores or the ability to inhibit tics19.
GABA concentrations in the SMA, measured using magnetic resonance spectroscopy, were significantly higher in 15 adolescents with
TS compared to 14 age- and gender-matched controls; there were no
group differences for GABA concentrations within M1 or primary
visual cortex20. The fMRI BOLD signal change within SMA was
negatively correlated with SMA GABA levels supporting the idea
that Magnetic Resonance Spectroscopy (MRS)-GABA concentrations are associated with localized increases in tonic inhibition. In a
small subset of TS subjects, single-pulse transcranial magnetic stimulation (TMS) delivered to the hand area of the left M1 region preceding movement of the right hand revealed a significant negative
correlation between MRS-GABA in the SMA and cortical-spinal
excitability within the left M1. Fractional anisotropy values within
the corpus callosum for TS subjects were positively correlated with
the SMA GABA values and with motor tic severity. These authors
suggest that enhanced control over volitional movements and tic
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suppression may be the result of increased tonic inhibition due to
the localized increases in extracellular GABA within SMA.
Eight adult subjects who completed Comprehensive Behavioral
Intervention for Tics (CBIT) treatment were compared with matched
controls on a visual priming task that was used to measure response
inhibition21. No significant between-group differences were found
in task-related BOLD signal in regions of interest (putamen, caudate, and prefrontal cortex regions BA 11, 44 and 47) before or
after CBIT training (with retesting over a comparable amount of
time for controls). However, there was a significant group by time
interaction because putamen activation decreased in the TS subjects
from time 1 to time 2 while it increased in the control subjects. A
significant negative correlation between change in inferior frontal
gyrus activation and change in YGTSS Total Tic Scores was also
found. The authors point out that this result is somewhat difficult to
interpret given that prior research has indicated that frontal regions
are involved in tic suppression.
Caveats... Several groups have recently studied the substantial effects
small head motions can have on BOLD fMRI. It is becoming apparent that many of the established techniques to control for movement
effects are frequently not sufficient. Functional connectivity analyses have been especially affected, since small head movements during scanning can produce artifactual connectivity signal (i.e., bias
not just noise). Fortunately, robust methods exist for preventing such
artifact, at the cost of potentially longer acquisition times22. However, movement also interferes with task fMRI analysis. In one task
fMRI study of 73 TS subjects ranging in age from 9–15 years of age,
only 38 subjects remained after excluding subjects with less than
70% accuracy on a rule-switching task and with at least 3 runs out of
6 with root-mean-square head movement estimates below 1.5 mm23.
This is not all explained by tics, since 33 of 53 healthy, tic-free children aged 7–9 were excluded for task accuracy <60% or head motion
> 1.5 mm (rms). Even with these relatively stringent requirements,
frame-by-frame motion censoring excluded an additional 15–20%
of the data. However, this approach bought cleaner signal; motion
censoring performed better than all forms of motion regression23.
Minor head motion has been shown to affect structural brain imaging as well. Diffusion MRI is especially sensitive to motion24. A
recent study showed that small head movements that do not cause
visible artifact in structural brain images can also produce spurious
reductions in estimated gray matter volume or cortical thickness25.
Many studies provide minimal information about the specific methods used to control for movement in a patient population that by definition is going to exhibit more movement than the average subject.
Therefore inadequate control of subject movement may have contributed to some of the inconsistent results in past neuroimaging studies.

Phenomenology and natural history
The urge made me do it. Premonitory urges have been considered
to have an important role in tic generation, and CBIT includes using
a competing response to prevent a tic from occurring until the urge
decreases sufficiently so that the tic will not occur. A number of
articles in 2014 addressed how premonitory sensations and urges
relate to tics and tic suppression.

Capriotti et al.33 examined the effects of negative reinforcement
on premonitory urges in 13 children and adolescents with TS or
chronic tic disorder (CTD). Subjects rated their urges to tic during three conditions: baseline during which they freely ticced, reinforced tic suppression and reinforced tic suppression with escape.
During the escape condition, subjects could initiate a 10 second
break during which they could freely tic. When the break was over,
the reinforced tic suppression began again. Tic rates were significantly lower during reinforced suppression conditions compared
to baseline free-to-tic conditions, although tic rates were significantly higher during the breaks in the escape condition compared
to non-break periods. Urge ratings were significantly higher during
the reinforced tic suppression conditions compared to the baseline
periods and in the escape condition, urge intensity went down from
break onset to the end of a break. These results support the hypothesis that premonitory urges are maintained through a process of
negative reinforcement.
Many people with tics say that they perform tics to decrease the
intensity of premonitory urges because the urges are so bothersome. The relationship between feelings of discomfort and habituation was studied in 90 healthy undergraduate humans with no tic
diagnosis34. A 2×2 experimental design was used with subjects either
receiving an air puff to the eye or hearing a sound, and either receiving an instruction to blink or no instruction to blink. When subjects
received the air puff and instructions to blink, the air puff was less
annoying but the EMG response of the orbicularis oculi muscle
continued and the length of the EMG response actually increased.
When subjects received the air puff without any instructions about
blinking, habituation to the air puff occurred. These results indicated that blinking was reinforced by the decrease in annoyance
and yet this process also prevented habituation from occurring. A
similar process may establish the association between premonitory
urges and tic behaviors; if so, this study may provide an interesting
“animal” model of tics for certain studies.
Treatment-naive children and teenagers with chronic tic disorders
were compared while being allowed to tic freely and while receiving reinforcement for suppressing their tics35. Attentional difficulties and age did not affect ability to suppress tics. Interestingly,
subjects were able to suppress tics associated with more intense
urges just as much as tics associated with less intense urges.
The Premonitory Urge for Tics Scale (PUTS)36 has been the primary instrument for evaluating premonitory urges in children and
adolescents. A 9 item version is frequently used because one item
(“I am able to stop my tics, even if only for a short period of time”)
did not correlate well with other test items. Interest in determining
the reliability and validity in older adolescents and adults produced
several studies that were published in 2014. The 10-item PUTS was
completed by 102 adults at two specialist clinics. Again item 10
demonstrated relatively low item-total correlation, consistent with
the idea that tic suppression and premonitory urges may reflect different mental processes37. The PUTS total score correlated only
slightly with scores on the Motor tic, Obsessions and Compulsions,
Vocal tic Evaluation Survey (MOVES) (total 0.34, motor 0.28,
vocal 0.27), supporting the view that tics and premonitory urges
may involve different processes. In general, however, the PUTS was
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considered to have acceptable reliability and validity when used
with adults. Another study examined PUTS scores in 122 older adolescents and adults with TS or CTD38. A third study examined the
use of the PUTS in 100 adults with TS39. PUTS scores were related
to obsessive-compulsive symptoms, anxiety, attentional problems
and quality of life. Half of the total sample had “pure” TS while
the other half had comorbid conditions (including 23 with OCD,
15 with ADHD, and 6 with anxiety). For patients with “pure” TS,
premonitory urges were negatively related to quality of life scores
while a weaker relationship was seen between these two variables
for patients with comorbid conditions. When stepwise multiple
linear regression analyses were performed, PUTS scores for the
“pure” subgroup were only predicted by MOVES obsessive-compulsive subscale scores, while for the subgroup with comorbidities
only anxiety scores were predictive of premonitory urges.
At this time the PUTS is the only empirically validated measure of
premonitory urge severity. However, Capriotti et al. pointed out that
the PUTS is relatively insensitive to change and is of limited validity in children under the age of 1033. They suggested the number
of breaks taken during the tic suppression reinforcement + escape
trials as an alternative way of measuring premonitory urge intensity.
New approaches to quantifying urge intensity would be welcome.
What generates and maintains tics? Two stress-induction tasks
(i.e., public speech, discussion of family conflict) were used to
study 8 TS children with comorbid anxiety40. Tic frequency did not
increase during periods of increased heart rate, and during the public speech task tic frequencies were actually lower during periods
of increased heart rate. The authors point out the only psychophysiological measure of stress used in this study was heart rate and that
future studies may benefit from simultaneously assessing a variety
of measures of stress (e.g., respiratory rate, ECG, eye tracking) and
examining effects on premonitory urge intensity in addition to tic
occurrence.
They went away. Shprecher et al. reported a retrospective follow-up
study of tic remission41. A brief survey was used to assess current
symptoms of 53 TS patients who were 13–31 years old and had
been seen previously in a TS clinic. At the time of the follow-up
subjects were seen in person or contacted by telephone. The survey
results were consistent with past research about TS and comorbid
ADHD and OCD. Mean symptom onset was age 7.9 for both tics
and ADHD and 9.2 for OCD. Peak symptom severity was reported
to be around age 11–13 for all three conditions with a decline in
symptom severity beginning around age 14–15. Symptom remission was reported in 32%, 23%, and 21% of subjects for tics,
ADHD, and OCD respectively.
Limited longitudinal follow-up data are available for tic disorders
other than TS. Bisker and colleagues reviewed 43 children with
no prior diagnosis of Tourette syndrome who had been diagnosed
with ocular tics by a pediatric neuro-ophthalmologist42. An average
of 6 years after their initial consultation, 32 of the children were
located for follow-up. Of these, 44% had persistent ocular tics, 9%
had developed nonocular motor tics, and 16% had developed both
nonocular motor tics and vocal tics. In other words, the tic disorder
remitted in less than a third of the patients available for follow-up.

Treatment
Medication. The effectiveness of dopamine D2-like receptor antagonists for treating tics is well-established46,72. Recently ecopipam,
a selective D1 receptor antagonist, was used in an 8-week openlabel study in 18 TS adults, 15 of whom completed the study73.
The mean YGTSS total tic score decreased from 30.6 at baseline
to 25.3 at the end of the trial. There was no worsening of ADHD or
OCD symptoms. Interestingly, there was no change in the intensity
of premonitory urges as measured by the PUTS scale, suggesting
that patients may have felt more able to resist the urges to perform
tics. There was no weight gain associated with taking ecopipam,
as is seen with most D2 antagonists. The results of this pilot study
suggest the value of conducting a larger double-blind study. Given
that this medication has a different mechanism of action than the
medications currently available to treat tics, it may prove useful for
the nontrivial number of patients who have responded inadequately
to currently available medications.
Wijemanne et al.74 provide a retrospective chart review of patients
treated with fluphenazine at a movement disorders referral center
over a 26-year period. Fluphenazine is a high-potency typical antipsychotic. Only patients who had at least one follow-up office visit
or telephone interview were included in the study. A total of 268
patients were included in the study; they had taken a mean daily fluphenazine dose of 3.24 mg for an average of 2.6 years. Improvement
was judged to be moderate to marked in four fifths of patients, with
side effects in one fourth. Tardive dyskinesia was not observed.
Deep brain stimulation. Deep brain stimulation (DBS) is a promising
treatment option for highly selected TS patients refractory to more
conservative treatments50,75. Several reports published in 2014 provide open-label follow-up on deep brain stimulation (DBS) in more
than a few TS patients. Several groups had targeted the internal segment of the globus pallidus (GPi)76–78. At follow-up intervals of from
8 to 80 months, most patients tolerated the treatment well and mean
symptomatic improvement compared to pre-surgery was 40–50%.
Another group reported open-label 6- and 12-month follow-up of 8
patients after DBS to the ventral anterior and ventrolateral thalamus79.
Angelov and colleagues80 studied DBS in rats bred for high prepulse
inhibition (PPI) of the startle reflex, an electrophysiological marker
that is elevated in TS and some other illnesses. This allowed direct
comparison of results (in terms of PPI reduction) among several different previously proposed target sites for DBS in TS. They found
that thalamic stimulation (of the centromedian-parafascicular complex) best reduced PPI and nucleus accumbens less so. Importantly,
implantation of leads in the entopeduncular nucleus (the rodent
homolog of the primate GPi) reduced PPI, but DBS itself added no
additional benefit; this result helps demonstrate why randomized,
blinded studies are crucial in evaluating invasive treatments.
Behavior therapy really works. Behavior therapy has been studied as a treatment for tics for many years26. However, its adoption
in clinical practice has lagged for a number of reasons27. A metaanalysis that appeared in 2014 may help convince skeptics of its
efficacy. The meta-analysis included 8 randomized control trials of
TS behavior therapy with a total of 438 TS subjects28. There was no
evidence of publication bias. Treatment effects were in the medium
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to large range, with a number needed to treat (NNT) of only 3, comparable to the most effective class of medications (antipsychotics).
Participants who were more likely to respond to behavior therapy
were older, had more therapeutic contact and were less likely to
have comorbid ADHD. At this point, the evidence base for behavior
therapy’s efficacy in treating tics is stronger than for any other class
of treatments except antipsychotics26.
Although research continues to demonstrate the value of behavioral
treatments such as CBIT, a limited number of therapists have been
trained to administer CBIT. Given the distance that many patients
live from potential therapists there is a need for alternative forms of
treatment. Blount et al. reported on treatment administered using an
intensive outpatient procedure (i.e., several hours daily over a four
day period) to two pediatric outpatients. This treatment resulted in
significant tic reductions that were maintained at follow-up 6 to
7 months later29. This form of treatment may be more convenient
for patients and their families who need to travel a significant distance for treatment, but a randomized controlled trial will be needed
to replicate these promising results.
Do exercise and biofeedback work? A small group of 18 participants, ranging in age from 10 to 20 years old, performed an Xbox®
kickboxing exercise routine with a 5-minute easy exercise session
followed by a 2-minute break and then a 5-minute exercise session
that was more physically demanding30. Tic counts based on video
recordings were lower during both exercise sessions compared to
during a baseline interview (i.e., completion of the Physical Activity
Questionnaire for Adolescents, discussion about hobbies and other
leisure activities). Interestingly, tic frequency was higher during the
more demanding exercise session (which also occurred after the subjects had been exercising for a longer amount of time) than during
the easier exercise session. Although tic frequency increased significantly during a second interview completed about 30 minutes after
the end of the exercise sessions, the frequency was still below that
seen during the pre-exercise baseline. Exercise also resulted in significantly reduced self-reported anxiety which was maintained during the post-exercise interview. It was suggested that exercise might
have been effective in reducing tic frequency because it improved
executive control functions, or because it served as a distraction task
taking attention away from the tics, or because exercise functioned
as a competing response which made it more difficult to perform the
tics. Behavioral treatments, such as CBIT, tend to involve multiple
components and, consequently, it is difficult to determine whether
all components are necessary for all patients. Using a simple intervention such as that used by Nixon et al. may make it easier to identify the underlying mechanism that makes the intervention effective
and may help identify whether certain patient subgroups are more
likely to respond to a particular treatment component.

ment protocol might increase effectiveness. The sham procedure,
which involved providing feedback to subjects so that they thought
that they were successfully altering their electrodermal activity, also
resulted in a significant decrease in tics. This is surprising since
placebo effects are minimal in pharmacological trials32.

Old and new
The most recent International Scientific Symposium on Tourette
Syndrome (New York, 2009) led to a set of review articles on TS
updated for publication in 201427,43–50. Also in 2014 the Tourette
Association of America announced that it had joined with two
European TS groups to sponsor the “First World Congress on
Tourette Syndrome and Tic Disorders”, held in London in June,
2015 (http://touretteworldcongress.org). Finally, it is difficult to
resist pointing out that 2014 also marked the introduction of a publication channel devoted entirely to tics, F1000Research: Tics51.
New submissions are warmly invited!

Discussion
We have provided summaries of some of the articles published in
2014 that we think will contribute to further advances in the field.
They cover a variety of topics: genetics, animal models, neuroimaging, and pharmacological and nonpharmacological treatment. The
choice of articles was admittedly subjective and most likely incomplete; in fact, we have listed a few more papers in Box 1. However,
one of the beauties of this publication venue is that readers who feel
we have misjudged are welcome to add their own recommendations
to the comments section of this article online.
We look forward to reprising this “highlights” page at the end of
2015, and would be grateful for article nominations or other suggestions from readers. Box 2 starts off this process by listing some
meeting presentations and preprints that caught our interest but had
Box 1. Additional 2014 publications of interest

“Altered synaptic plasticity in Tourette’s Syndrome and its
relationship to motor skill learning”52
“Environmental circumstances influencing tic expression in
children”53
“The modulating role of stress in the onset and course of
Tourette’s Syndrome: A review”54
“Tic-related obsessive-compulsive disorder (OCD):
Phenomenology and treatment outcome in the Pediatric OCD
Treatment Study II”55
“Set-shifting deficits: A possible neurocognitive endophenotype
for Tourette Syndrome without ADHD”56
“Variables associated with tic exacerbations in children with
chronic tic disorders”57
Prenatal and perinatal risk factors for TS58

A preliminary randomized controlled trial examined electrodermal biofeedback during three 30-minutes sessions each week for
4 weeks in 21 adults with TS31. Both sham and actual biofeedback
produced similar decreases in tic frequency and similar improvements in well-being. The authors noted that tics occurring during
the biofeedback sessions resulted in competing phasic electrodermal
arousal responses making it difficult for patients to sustain a reduction in sympathetic tone, suggesting that modifications in the treat-

Prenatal risk factors for TS81
“Tics are caused by alterations in prefrontal areas, thalamus and
putamen, while changes in the cingulate gyrus reflect secondary
compensatory mechanisms”59
“Meta-cognitions in Tourette syndrome, tic disorders, and
body-focused repetitive disorder”60
“Dysregulated intracellular signaling in the striatum in a
pathophysiologically grounded model of Tourette syndrome”61
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Box 2. Work to look for in 2015

“Don’t look”: seeing your own tics makes them more frequent62

not appeared in final form by the end of 2014. We hope that 2015
brings important breakthroughs in our understanding of the causes,
mechanisms and treatment of tic disorders.

Astrocyte metabolism in TS70
Functional connectivity and machine learning in TS63
Reward enhances tic suppression very early in the course of tic
disorders64
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Methods: it would be helpful to know the approximate denominator of articles reviewed, and what
proportion were selected.
Results: it would be helpful to know how/why topic areas were chosen. Weight seemed to lean strongly
toward neuroimaging, which may reflect the authors’ primary interests and expertise. Organization of topic
areas could be improved; as it stands, the reader is moved from neuroscience (animal models, imaging)
to behavior therapy, premonitory urges, and longitudinal course, and then back to neuroscience
(genetics). It might read more easily to start with basics (neuroscience, genetics, neuroimaging) through
phenomenology (course, urges, role of stress) to treatment.
The manuscript could be improved with the inclusion of pharmacotherapy updates; although the
Discussion summarized that the “broad spectrum of articles” covered “animal models, neuroimaging, and
pharmacological and non-pharmacological treatment,” the only treatments discussed were behavior
therapy, exercise and biofeedback.
Suggested pharmacotherapy additions include:
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Gilbert, D. et al.: “A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette Syndrome” Clin
Neuropharmacol 2014; 37 (1) 26-30
Malaty, I.A. and Akbar U: Updates in Medical and Surgical Therapies for Tourette Syndrome; 2014; Curr
Neurol Neurosci Rep 14: 458; this is a review with an annotated bibliography.
Work to look for in 2015: Bachmann, CJ et al.: Trends in Psychopharmacological Treatment of Tic
Disorders in Children and Adolescents in Germany; Eur Child Adolesc Psychiatry 2015; 24 (2); 199-207
Lastly, there appeared to be a relative lack of articles on aspects of psychiatric comorbidity. Of particular
interest is the recently published study from the Tourette Syndrome Association International Consortium
for Genetics:
Hirschtritt, M. et al.: Lifetime Prevalence, Age of Risk, and Genetic Relationships of Comorbid Psychiatric
Disorders in Tourette Syndrome; JAMA Psychiatry doi:10.1001/jamapsychiatry.2014.2650
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Competing Interests: No competing interests were disclosed.
Author Response ( F1000Research Advisory Board Member ) 30 Jun 2015

Kevin J Black, Department of Psychiatry, Washington University in St. Louis, USA
We thank Dr. Coffey for her very thoughtful comments, and have revised the manuscript
accordingly. Replies to specific comments follow.
Requests the “approximate denominator of articles reviewed.”
We read at least the abstract from the 200 papers identified in the PubMed searches. We
have added this number to the introduction. We cite well over 50 of them. Originally we
intended to discuss only about 5 or 10 papers, but it was harder than expected to omit
anything.
“It would be helpful to know how/why topic areas were chosen … may reflect the
authors’ primary interests”
Doubtless the selection of articles reflects some influence of our own interests. As you
noted, we at least warned the reader that our selection was arbitrary. We attempted to
respond to the theme of what reports were most likely to be of greatest interest in the future,
and we now explain this choice in the first sentence of Results.
“Organization of topic areas could be improved”
Thank you for the useful suggestion. We have rearranged the topics in a more structured
fashion: Etiology, pathophysiology, phenomenology and natural history, and treatment.

We left out pharmacology
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We left out pharmacology
We agree. Please see our comments in the response to Dr. Martino's review about Gilbert et
al. We have added the Malaty and Akbar citation to the treatment section, and the
Bachmann et al. review to Box 2.
“Relative lack of articles on … psychiatric comorbidity.” Recommends Hirschtritt et
al. 2015.
We are also very interested in psychiatric comorbidity, and we agree that the Hirschtritt et al
article is very important. As it was published in April, 2015, we added it to Box 2.
Competing Interests: No competing interests were disclosed.
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doi:10.5256/f1000research.6659.r8212
Davide Martino
Department of Neurology, King's College London, Hospital NHS Foundation Trust, London, UK
I enjoyed reading this useful and well written contribution.
I have a few comments:
1. In the subsection of Results entitled “Other animal models”, the reader might benefit from a brief
explanation of the model presented by McCairn et al: did this use a GABA antagonist like
bicuculline?
2. In the subsection entitled “A look inside: neuroimaging studies”, I personally found interesting a
paper which is not cited and evaluates the potential of deep repetitive transcranial magnetic
stimulation (deep rTMS) to the supplementary motor area (Bloch et al.,2014)
3. In respect to neurobiofeedback, as commented on in page 4, another useful paper on ADHD and
tic disorders is Gevensleben et al. (2009). Moreover, a 2015 citation focusing on neurofeedback is
this useful review: Farkas et al. (2015).
4. My main criticism is that there is no citation at all about deep brain stimulation, which is an area
currently avidly investigated in Tourette syndrome. It is possible that the authors felt that none of
the articles published in 2014 on DBS in Tourette syndrome is sufficiently interesting, but I would at
least discuss this in the article and add the following citation in Box 2: Schrock et al., (2015).
5. Additional 2014 publications of interest:
Chao TK, Hu J and Pringsheim T: Prenatal risk factors for Tourette syndrome: a systematic review.
BMC Pregnancy and Childbirth. 2014; 14(53).
Gilbert DL, Budman CL, Singer HS, et al:, A D1 receptor antagonist, ecopipam, for treatment in
Tourette syndrome. Clin Neuropharmacol. 2014; 37(1): 26-30.
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Tourette syndrome. Clin Neuropharmacol. 2014; 37(1): 26-30.
Wijemanne S, Wu LJ and Jankovic J: Long-term efficacy and safety of fluphenazine in patients
with Tourette syndrome. Mov Disord. 2014; 29(1):126-130.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
Competing Interests: No competing interests were disclosed.
Author Response ( F1000Research Advisory Board Member ) 30 Jun 2015

Kevin J Black, Department of Psychiatry, Washington University in St. Louis, USA
We appreciate Dr. Martino's thoughtful comments and have used them to improve the manuscript
for version 2.
1. Brief explanation of the model presented by McCairn et al.
Yes, this used bicuculline injected into the putamen or nucleus accumbens; we have added
this to the manuscript.
2. Recommends Bloch et al.
This is a very interesting article, but the final version was not yet published as of May, 2015.
We have added it to Box 2.
3. "In respect to neurobiofeedback, as commented on in page 4, another useful paper
on ADHD and tic disorders is Gevensleben et al. (2009). Moreover, a 2015 citation
focusing on neurofeedback is this useful review: Farkas et al. (2015)."
Good articles. Readers can find the citation to Gevensleben et al. 2009 in your comments.
We have added the Farkas et al. (2015) reference to Box 2.
4. No citation about DBS.
We agree this is an important area of work in TS, but relatively few DBS papers on TS were
published in 2014. We have added a paragraph on DBS, and have added the important
2015 paper you suggested to Box 2.
5. Recommends Chao et al., prenatal risk factors for Tourette syndrome
We agree and have added this to Box 1.
Recommends Gilbert et al., ecopipam study
This paper was overlooked by accident. We agree this was an important pilot study on a
potentially new avenue of treatment for TS and have added a short paragraph.
Recommends Wijemanne et al., fluphenazine report.
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Recommends Wijemanne et al., fluphenazine report.
Thank you. We have added this to the section on medication treatment.
Competing Interests: No competing interests were disclosed.

Discuss this Article
Version 2

Author Response ( F1000Research Advisory Board Member ) 08 Oct 2015

Kevin J Black, Department of Psychiatry, Washington University in St. Louis, USA
We have begun an online draft of a 2015 update of this article, and would be grateful for any constructive
feedback. The platform allows readers to leave comments on the little balloon icon at the upper right
corner of each section of the article.
I'm thinking about allowing "in press" and "Epub ahead of print" articles this year. It has obvious benefits for
timeliness, so I should explain why I didn't in the 2014 article above. I did not want to collude with journals
that exploit increasing delays in their "official" paper publication dates to increase journal impact factor
while simultaneously delaying free access to the public on PubMedCentral. Given the timely publication
benefit of F1000Research, such delays increasingly rankle.
Competing Interests: No competing interests were disclosed.

Author Response ( F1000Research Advisory Board Member ) 19 Jul 2015

Kevin J Black, Department of Psychiatry, Washington University in St. Louis, USA
I omitted this citation for the matplotlib library used in creating Figure 1:
Hunter JD: Matplotlib: A 2D graphics environment. Computing In Science & Engineering 9(3):90-95, 2007.
Competing Interests: No competing interests were disclosed.

Version 1

Author Response ( F1000Research Advisory Board Member ) 17 Mar 2015

Kevin J Black, Department of Psychiatry, Washington University in St. Louis, USA
The (U.S.) Tourette Syndrome Association highlights some articles a couple of times a year in their
newsletter. Their focus overlaps ours. Their links are here.
Competing Interests: none
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Author Response ( F1000Research Advisory Board Member ) 16 Mar 2015

Kevin J Black, Department of Psychiatry, Washington University in St. Louis, USA
Here's another contribution to Box 2 (articles to look for in 2015). This interesting article from my
colleagues and mentee just appeared in "online early" form:
Stewart SB, Greene DJ, Lessov-Schlaggar CN, Church JA, Schlaggar BL: Clinical correlates of parenting
stress in children with Tourette syndrome and in typically developing children.
doi:10.1016/j.jpeds.2015.01.041
Competing Interests: Colleagues
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